x

Coronavirus

UK Regulator: People Should Keep Getting AstraZeneca Shots

LONDON — British regulators said Thursday that people should keep getting AstraZeneca's COVID-19 vaccine following its review of data on patients who suffered from blood clots after getting the shot.

The Medicines and Healthcare Products Regulatory Agency said there's no evidence that the vaccine causes blood clots in veins. A further review of five reports in the U.K. of a rare type of clot in the brain is continuing, but the condition, which can occur naturally, has been reported in less than 1 in a million people vaccinated so far and no causal link has been established, the agency said.

"The MHRA's advice remains that the benefits of the vaccines against COVID-19 continue to outweigh any risks and that the public should continue to get their vaccine when invited to do so,'' the agency said.

RELATED

NEW YORK (AP) — President Joe Biden promised to distribute hundreds of millions of free COVID-19 tests and to open more testing sites to fight surging infections, but the stepped-up efforts will not come in time for people who want to find out if they are infected before the holidays.

Top Stories

Society

ATHENS — A severe weather front has hit Greece, with below-freezing temperatures and snowfall in many parts of the country, including the capital Athens and many Aegean islands.

Events

BROOMALL, PA – The community of St Luke in Broomall held the annual cutting of the Vasilopita event on January 23.

Society

ATHENS – Women in Greece – those who survive – are coming out to report domestic violence that has become endemic in the county, with 5,705 cases in the first 10 months of 2021, when there was a rash of femicide.

Video

Biden Caught on Hot Mic Swearing at Fox News Reporter

WASHINGTON — President Joe Biden responded to a question about inflation by calling a Fox News reporter a vulgarity.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.